πŸ‡ΊπŸ‡Έ FDA
Patent

US 6589507

Foaming antacid suspension tablets

expired A61KA61K33/08A61K33/10

Quick answer

US patent 6589507 (Foaming antacid suspension tablets) held by DR. Regenold GmbH expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
DR. Regenold GmbH
Grant date
Tue Jul 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K33/08, A61K33/10, A61K33/12, A61K33/42